1. 1258PBaseline predictive factors for efficacy of anti-PD1 used in first line in melanoma patients: An Italian melanoma intergroup study. (23rd October 2018) Authors: Marconcini, R; Tanda, E; Di Guardo, L A; Nigro, O; Fava, P; Todisco, A; Morgese, F; Cortellini, A; Stroppa, E; Gallizzi, G; Festino, L; Grego, E; Quadrini, S; Orlandini, C; Nuzzo, A; Manacorda, S; Bloise, F; Indini, A; Astrua, C; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1423PPre-treatment EGFR-T790M subclones in lung adenocarcinoma harboring activating mutation of EGFR: A positive prognostic factor for survival?. (23rd October 2018) Authors: Prediletto, I; Vasile, E; Bruno, R; Macerola, E; Pasquini, G; Fontanini, G; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 145PExpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical response to CDK4/6 inhibitors in breast cancer. (23rd October 2018) Authors: Crucitta, S; Del Re, M; Fontana, A; Bertolini, I; Rofi, E; De Angelis, C; Diodati, L; Cavallero, D; Salvadori, B; Falcone, A; Morganti, R; Danesi, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 169PSelective induction of PD-L1 expression in plasma-derived exosomes by gemcitabine-nab-paclitaxel vs. FOLFIRINOX in pancreas cancer. (23rd October 2018) Authors: Rofi, E; Del Re, M; Vivaldi, C; Crucitta, S; Arrigoni, E; Pasquini, G; Catanese, S; Pecora, I; Musettini, G; Vasile, E; Falcone, A; Danesi, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 463PReal-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study. (23rd October 2018) Authors: O'Connor, J M; Ducreux, M; Petersen, L N; Öhler, L; Bergamo, F; Metges, J-P; de Groot, J W; Wang, J-Y; García Paredes, B; Dochy, E; Fiala-Buskies, S; Cervantes, A; Falcone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 464PSafety and efficacy of trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer (mCRC) patients according to previous treatment with regorafenib in the international phase IIIb PRECONNECT study. (23rd October 2018) Authors: Taieb, J; Falcone, A; Lonardi, S; Price, T J; Bachet, J-B; Wyrwicz, L; Ciardiello, F; Becquart, M; Mounedji, N; Van Cutsem, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 88PRole of AR-V7 and AR-FL in resistance to hormonal therapy in mCRPC: Independent actors or reciprocal drivers? A translational study by Meet-Uro group. (23rd October 2018) Authors: Del Re, M; Crucitta, S; Sbrana, A; Rofi, E; Paolieri, F; Galli, L; Falcone, A; van Schaik, R; Jenster, G; Morganti, R; Pignata, S; Danesi, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Experiences in simplifying distributed simulation: The HLA development kit framework. Issue 3 (1st August 2017) Authors: Falcone, A; Garro, A; Taylor, S J E; Anagnostou, A; Chaudhry, N R; Salah, O Journal: Journal of simulation Issue: Volume 11:Issue 3(2017) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Gamma-ray observations of MAXI J1820+070 during the 2018 outburst. Issue 4 (23rd September 2022) Authors: Abe, H; Abe, S; Acciari, V A; Aniello, T; Ansoldi, S; Antonelli, L A; Arbet Engels, A; Arcaro, C; Artero, M; Asano, K; Baack, D; Babić, A; Baquero, A; Barres de Almeida, U; Barrio, J A; Batković, I; Baxter, J; Becerra González, J; Bednarek, W; Bernardini, E Journal: Monthly notices of the Royal Astronomical Society Issue: Volume 517:Issue 4(2022) Page Start: 4736 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies. (1st October 2019) Authors: Marmorino, F; Rossini, D; Lonardi, S; Moretto, R; Zucchelli, G; Aprile, G; Dell'Aquila, E; Ratti, M; Bergamo, F; Masi, G; Urbano, F; Ronzoni, M; Libertini, M; Borelli, B; Randon, G; Buonadonna, A; Allegrini, G; Pella, N; Ricci, V; Boccaccino, A Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1969 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗